The Column Group
Accelerator🇺🇸 United StatesInvestment thesis
Science-driven firm with deep fundamental scientific principles, primarily focused on company formation via an 'edge-to-edge' model with the financial wherewithal for long-term private and public support. Backs scientifically-driven teams making big, innovative leaps toward therapeutic breakthroughs.
Notable portfolio
NGM BiopharmaceuticalsNurix Therapeutics
Sector focus
BiotechTherapeuticsLife sciences